Thursday, April 23, 2026

Will Pancreatitis Kill Me If I Keep Drinking? A Deep Dive Into the Risks, Science, and Realities

will pancreatitis kill me

If you’ve had a bout of pancreatitis—or worse, if you’re living with chronic pancreatitis—the question isn’t just “should I quit drinking?” It’s “what’s really going to happen to me if I don’t?” The answer is blunt: continuing to drink with pancreatitis isn’t just a bad idea. It’s dangerous, and it can absolutely cost you your life. Let’s go beyond the surface, break down the science, and look at what really happens, step by step, if you keep drinking after a pancreatitis diagnosis.

How Alcohol Wrecks the Pancreas

The pancreas is a tough little organ, but alcohol is its kryptonite. Here’s what happens:

  • Direct Toxicity: Alcohol and its byproducts are directly toxic to pancreatic cells. They cause inflammation, cell death, and eventually scarring (fibrosis).
  • Disrupting Enzyme Flow: Alcohol promotes the premature activation of digestive enzymes inside the pancreas, so the gland essentially starts digesting itself.
  • Triggering Immune Overreaction: Repeated alcohol exposure stirs up the body’s immune response, making inflammation worse and leading to more tissue damage.
  • Gut Barrier Breakdown: Chronic drinking upsets the balance of gut bacteria and increases gut permeability (“leaky gut”), allowing toxins to reach the pancreas and fuel more inflammation.

The Vicious Cycle: Acute Attacks Turning Chronic

  • Acute Pancreatitis: Starts with a sudden, severe attack—intense abdominal pain, vomiting, and sometimes organ failure. Alcohol is a leading cause, especially among adults.
  • Chronic Pancreatitis: Ongoing drinking turns acute attacks into a chronic, smoldering fire. The pancreas loses its ability to heal, and healthy tissue gets replaced by scar tissue.

What This Means for Your Body

  • Digestive Failure: The pancreas can’t produce enough enzymes, so you lose weight, your stools become oily and foul-smelling, and you can’t absorb nutrients. Malnutrition becomes a real risk.
  • Diabetes: As insulin-producing cells are destroyed, blood sugar goes haywire. Up to 80% of people with chronic pancreatitis end up with diabetes (“Type 3c”).
  • Constant Pain: Chronic pain can be relentless, sometimes requiring strong narcotics just to function day-to-day.
  • Dangerous Complications: You’re at high risk for things like pancreatic pseudocysts (fluid collections that can rupture or get infected), internal bleeding, and blockages of the bile duct.

The Life-Threatening Risks

Here’s where it gets real:

  • Organ Failure: Severe attacks can cause the pancreas to release massive amounts of inflammatory chemicals, triggering a cascade that shuts down the kidneys, lungs, and heart (multi-organ failure). This is a leading cause of death in acute pancreatitis.
  • Infections: Damaged pancreatic tissue is a breeding ground for bacteria. Infected necrosis (dead pancreatic tissue) is very hard to treat and often fatal without aggressive intervention.
  • Internal Bleeding: The pancreas sits near major blood vessels. Inflammation and pseudocysts can erode into these vessels, causing catastrophic bleeding.
  • Pancreatic Cancer: Chronic pancreatitis—especially from ongoing alcohol use—significantly increases your risk of developing pancreatic cancer, which is one of the deadliest cancers around.

What Do the Studies Show?

  • Recurrent drinking after an initial episode of alcohol-induced pancreatitis dramatically increases the risk of future attacks, chronic pancreatitis, and death.
  • A 2017 study in The American Journal of Gastroenterology found that patients who continued to drink after a pancreatitis diagnosis had up to a four-fold higher risk of mortality compared to those who quit.
  • Long-term survival is markedly better in people who stop drinking. Stopping alcohol can stabilize or even improve pancreatic function and slow down the progression to end-stage disease.

Is There Any Safe Amount?

The answer is simple: No. Even “cutting back” isn’t enough. The medical consensus is that for anyone with a history of pancreatitis—especially alcohol-related—any alcohol is too much. The risk isn’t worth it.

What Happens If You Quit?

  • Your risk of future attacks drops dramatically—sometimes to nearly zero.
  • The progression of chronic pancreatitis can slow or even stop, preserving what function you have left.
  • Your risk of diabetes, malnutrition, and cancer decreases.
  • You’re likely to live longer and better.

Why Is It So Hard to Quit?

Alcohol dependence is real and powerful. If you’re struggling to quit, you’re not alone—and it’s not just about willpower. Withdrawal can be dangerous; trying to quit “cold turkey” after heavy use should be medically supervised. There are medications, therapies, and support groups (like AA or SMART Recovery) that can make all the difference.

The Bottom Line

If you keep drinking with pancreatitis, you’re risking everything—your health, your independence, your life. But the moment you stop, you start tipping the odds back in your favor. The pancreas can’t regenerate like a liver, but quitting drinking can halt the damage and save your life. If you’re struggling, reach out to your doctor. There is help. And there is hope.


Credits:

You get one pancreas—take care of it. And remember, reaching out for support is a sign of strength, not weakness.

Do I Have Pancreatitis? 10 Signs That Should Never Be Ignored

 

Acute Pancreatitis

Most people don’t spend a lot of time thinking about their pancreas. It’s one of those organs that quietly does its job—helping you digest food and control blood sugar—until something goes wrong. Then, it makes its presence known in a way you can’t ignore. Pancreatitis, or inflammation of the pancreas, is one of those health problems that can sneak up on you but can also turn serious fast if left untreated.

Do I Have Pancreatitis?

Wondering if you should be worried? Here are 10 signs of pancreatitis that you should never brush off:

Do I have pancreatitis?

1. Upper Abdominal Pain That Won’t Quit

The most classic sign is pain smack in the upper abdomen. It might start mild, but it usually gets worse—sometimes so bad it radiates to your back and makes it hard to stand up straight.

2. Nausea and Vomiting
Not the “I ate bad takeout” kind of nausea, but persistent, unrelenting nausea that doesn’t improve. If you’re throwing up and it’s not stopping, it’s time to get checked out.

3. Tenderness When You Touch Your Belly
Push gently on your upper abdomen. If it’s tender, swollen, or just feels off, that’s another red flag.

4. Fever and Chills
Running a fever isn’t just about catching a cold. If you have abdominal pain plus a fever, your body might be fighting off inflammation or infection in the pancreas.

5. Rapid Pulse
A fast heartbeat can be your body’s way of signaling distress. If you have pain and your pulse is racing, don’t ignore it.

6. Unexplained Weight Loss
Dropping pounds without trying might sound like a bonus, but if it comes with abdominal issues, your pancreas could be struggling to help you digest food.

7. Oily, Smelly Stools
The pancreas produces enzymes that help you break down fat. If it’s not working well, your stools can become pale, greasy, and float—often with a foul odor.

8. Jaundice (Yellowing of Skin or Eyes)
If your skin or the whites of your eyes start turning yellow, it could mean a blocked bile duct—a complication sometimes seen with pancreatitis.

9. Bloating and Fullness
You might notice your belly looks more swollen than usual, or you feel full quickly after eating even a small amount.

10. Low Blood Pressure or Dizziness
In severe cases, pancreatitis can cause dehydration or bleeding, which might drop your blood pressure and make you feel lightheaded or faint.

What Should You Do?

If you notice a combination of these symptoms—especially severe abdominal pain, vomiting, or jaundice—don’t try to tough it out. Pancreatitis can quickly become a medical emergency. The safest move is to head to the ER or urgent care, where doctors can run blood tests and imaging studies to figure out what’s going on.

And remember: not all abdominal pain means pancreatitis, but this isn’t something to self-diagnose or ignore. Better to be safe and get checked out than risk serious complications.


Credits:
Mayo Clinic, Cleveland Clinic, Johns Hopkins Medicine, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

If you’re worried about your symptoms, trust your gut (no pun intended) and see a healthcare professional. Your pancreas will thank you.

Tuesday, April 21, 2026

Daraxonrasib and the New Era in Pancreatic Cancer Treatment


The KRAS Challenge: Why Pancreatic Cancer Is So Tough

Pancreatic cancer has always posed a brutal challenge for doctors and researchers. The five-year survival rate has hovered around 10%, and most diagnoses come late, when the disease has already spread. A key reason for this stubbornness is a genetic culprit: mutations in the KRAS gene. KRAS was the first cancer-causing gene ever identified, but targeting it has been called “the Mount Everest of drug development” (TIME).

About 90% of pancreatic cancers (specifically pancreatic ductal adenocarcinoma, the most common type) are driven by these KRAS mutations, which act as a stuck accelerator for cell growth. For decades, every attempt to block KRAS directly failed—either the molecules couldn’t reach the target, or the side effects were too severe. Researchers started to think it was impossible.

What Makes Daraxonrasib Different?

Daraxonrasib, developed by Revolution Medicines, represents a fundamentally new approach. Rather than just trying to block KRAS directly, it binds with another protein inside the cell, forming a complex that disrupts the function of mutant RAS proteins (KRAS is part of the RAS family). This blocks the signals that tell cancer cells to grow and divide (Advisory Board).

The drug is taken orally, which is a huge advantage over traditional chemotherapies, which require IV infusions and often come with grueling side effects.

The Clinical Trial Results: What’s Actually Changed?

The pivotal Phase III trial focused on patients with metastatic pancreatic cancer who had already undergone standard therapies. These are patients for whom the outlook is especially grim. In this group, daraxonrasib delivered something unprecedented: it doubled median overall survival compared to standard intravenous chemotherapy (Jerusalem Post).

  • Progression-Free Survival (PFS): Patients lived significantly longer without their disease getting worse.
  • Overall Survival (OS): The median OS was nearly twice as long as with standard-of-care chemotherapy (RevMed IR).
  • Side Effects: While no cancer drug is free of side effects, daraxonrasib's oral formulation meant fewer hospital visits and a better quality of life for many patients.

Why the FDA Is Fast-Tracking Daraxonrasib

The FDA reserves fast-track status for drugs that address serious, unmet needs and show clear evidence of benefit. Pancreatic cancer has long been a graveyard for cancer drugs, so to see a therapy deliver such robust results—especially in late-stage patients—is a game-changer. The agency is accelerating its review, meaning daraxonrasib could become widely available much sooner than usual (CU Anschutz).

Beyond Metastatic Disease: The Next Frontier

Researchers are already looking at daraxonrasib in different settings:

  • Adjuvant Therapy: After surgery and chemotherapy, to prevent cancer from coming back (Facing Our Risk).
  • Earlier-Stage Patients: There are trials underway to see if patients diagnosed earlier might benefit even more.
  • Other RAS-Driven Cancers: Since RAS mutations are common in other tough-to-treat cancers (like lung and colorectal), the implications could reach far beyond pancreatic cancer.

The Big Picture: What Does This Mean for Patients?

For the first time, there’s a drug that not only extends life in metastatic pancreatic cancer, but does so in a way that’s manageable and accessible—a pill, not an infusion. Patients who once had weeks or months may now have a real shot at longer, more meaningful time with their families.

What Questions Remain?

  • Long-Term Safety: The drug is still new; ongoing monitoring will shed light on rare side effects.
  • Combination Therapies: Can daraxonrasib be paired with other targeted drugs or immunotherapies for even better outcomes?
  • Cost and Access: Will insurance cover it? Will it be affordable for all patients who need it?

Final Thoughts

Daraxonrasib isn’t just another drug—it’s proof that the “undruggable” can be drugged. It’s a testament to decades of research, the persistence of scientists, and the hope of patients who never gave up. If the results hold up in broader use, this could mark the start of a new era for one of the deadliest cancers we know.


Credits: This deep dive draws on reporting and research from TIME, The Jerusalem Post, CU Anschutz, RevMed IR, Advisory Board, and Facing Our Risk.